Increased IL-6 in sera of chronic lymphocytic leukemia (CLL) patients correlates with STAT3-dependent dampening of T cell proliferation and IL-2 production (99, 100). This evidence concerns the gene IL6 and B-cell chronic lymphocytic leukemia.